Neurobiological Technologies, Inc.
NTII
$0.00
$0.000.00%
OTC PK
| 12/17/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Revenue | 25.32M | 28.81M | 26.35M | 13.58M | 14.25M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.32M | 28.81M | 26.35M | 13.58M | 14.25M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 25.32M | 28.81M | 26.35M | 13.58M | 14.25M |
| SG&A Expenses | 3.89M | 4.43M | 4.88M | 5.32M | 5.84M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.23M | 16.16M | 22.07M | 28.38M | 33.39M |
| Operating Income | 20.09M | 12.65M | 4.28M | -14.80M | -19.13M |
| Income Before Tax | 18.72M | 11.39M | 3.12M | -14.49M | -19.12M |
| Income Tax Expenses | 53.00K | 96.00K | -- | -- | -- |
| Earnings from Continuing Operations | 18.67 | 11.29 | 3.12 | -14.49 | -19.12 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.67M | 11.29M | 3.12M | -14.49M | -19.12M |
| EBIT | 20.09M | 12.65M | 4.28M | -14.80M | -19.13M |
| EBITDA | 20.15M | 12.75M | 4.42M | -14.63M | -18.94M |
| EPS Basic | 0.70 | 0.42 | 0.12 | -0.54 | -0.71 |
| Normalized Basic EPS | 0.48 | 0.31 | 0.11 | -0.33 | -0.41 |
| EPS Diluted | 0.69 | 0.42 | 0.12 | -0.54 | -0.71 |
| Normalized Diluted EPS | 0.48 | 0.31 | 0.11 | -0.33 | -0.41 |
| Average Basic Shares Outstanding | 107.55M | 107.49M | 107.48M | 107.69M | 107.67M |
| Average Diluted Shares Outstanding | 107.56M | 107.50M | 107.48M | 107.69M | 107.67M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |